U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Transient aminoaciduria

MedGen UID:
870272
Concept ID:
C4024713
Finding
HPO: HP:0008273

Term Hierarchy

Conditions with this feature

Hereditary fructosuria
MedGen UID:
42105
Concept ID:
C0016751
Disease or Syndrome
Following dietary exposure to fructose, sucrose, or sorbitol, untreated hereditary fructose intolerance (HFI) is characterized by metabolic disturbances (hypoglycemia, lactic acidemia, hypophosphatemia, hyperuricemia, hypermagnesemia, hyperalaninemia) and clinical findings (nausea, vomiting, and abdominal distress; chronic growth restriction / failure to thrive). While untreated HFI typically first manifested when fructose- and sucrose-containing foods were introduced in the course of weaning young infants from breast milk, it is now presenting earlier, due to the addition of fructose-containing nutrients in infant formulas. If the infant ingests large quantities of fructose, the infant may acutely develop lethargy, seizures, and/or progressive coma. Untreated HFI may result in renal and hepatic failure. If identified and treated before permanent organ injury occurs, individuals with HFI can experience a normal quality of life and life expectancy.

Recent clinical studies

Diagnosis

Govindarajan S, Khandelwal P, Sharma S, Agarwala A, Sinha A, Hari P, Bagga A
Indian J Pediatr 2023 Feb;90(2):178-180. Epub 2022 Nov 3 doi: 10.1007/s12098-022-04372-0. PMID: 36324017
Kumagai N, Kondoh T, Matsumoto Y, Ikezumi Y
Tohoku J Exp Med 2022 May 28;257(1):73-76. Epub 2022 Mar 31 doi: 10.1620/tjem.2022.J015. PMID: 35354692
Lenain R, Hamroun A, Lion G, Chamley P, Bui L, Lionet A, Hazzan M, Provôt F
Medicine (Baltimore) 2019 Dec;98(52):e18478. doi: 10.1097/MD.0000000000018478. PMID: 31876733Free PMC Article
Jackson CB, Bauer MF, Schaller A, Kotzaeridou U, Ferrarini A, Hahn D, Chehade H, Barbey F, Tran C, Gallati S, Haeberli A, Eggimann S, Bonafé L, Nuoffer JM
Eur J Pediatr 2016 Apr;175(4):517-25. Epub 2015 Nov 13 doi: 10.1007/s00431-015-2661-y. PMID: 26563427
Yu JS, Walker-Smith JA, Burnard ED
Arch Dis Child 1971 Jun;46(247):306-9. doi: 10.1136/adc.46.247.306. PMID: 5090663Free PMC Article

Therapy

Lenain R, Hamroun A, Lion G, Chamley P, Bui L, Lionet A, Hazzan M, Provôt F
Medicine (Baltimore) 2019 Dec;98(52):e18478. doi: 10.1097/MD.0000000000018478. PMID: 31876733Free PMC Article
Stiff PJ, McKenzie RS, Potempa LD, Albain K, Koch D, Braud E, Bansal VK, Weidner MK, Lanzotti VJ, Chun HG
J Clin Oncol 1991 Aug;9(8):1487-94. doi: 10.1200/JCO.1991.9.8.1487. PMID: 2072148
Lindemann R
Acta Paediatr Scand 1991 Aug-Sep;80(8-9):882-4. doi: 10.1111/j.1651-2227.1991.tb11967.x. PMID: 1957611
Yu JS, Walker-Smith JA, Burnard ED
Arch Dis Child 1971 Jun;46(247):306-9. doi: 10.1136/adc.46.247.306. PMID: 5090663Free PMC Article
PARKES WE, NEILL DW
Br Med J 1953 Mar 21;1(4811):653-5. doi: 10.1136/bmj.1.4811.653. PMID: 13032436Free PMC Article

Prognosis

Stiff PJ, McKenzie RS, Potempa LD, Albain K, Koch D, Braud E, Bansal VK, Weidner MK, Lanzotti VJ, Chun HG
J Clin Oncol 1991 Aug;9(8):1487-94. doi: 10.1200/JCO.1991.9.8.1487. PMID: 2072148

Clinical prediction guides

Kumagai N, Kondoh T, Matsumoto Y, Ikezumi Y
Tohoku J Exp Med 2022 May 28;257(1):73-76. Epub 2022 Mar 31 doi: 10.1620/tjem.2022.J015. PMID: 35354692
Lenain R, Hamroun A, Lion G, Chamley P, Bui L, Lionet A, Hazzan M, Provôt F
Medicine (Baltimore) 2019 Dec;98(52):e18478. doi: 10.1097/MD.0000000000018478. PMID: 31876733Free PMC Article
Hayashi S, Nagata T, Kimura A, Tsurumi K
Tohoku J Exp Med 1978 Nov;126(3):215-23. doi: 10.1620/tjem.126.215. PMID: 734646

Supplemental Content

Table of contents

    Clinical resources

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...